Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial.
Lian B, Si L, Chi ZH, Sheng XN, Kong Y, Wang X, Tian H, Li K, Mao LL, Bai X, Tang BX, Yan XQ, Li SM, Zhou L, Dai J, Tang XW, Ran FW, Yao S, Guo J, Cui CL. Lian B, et al. Among authors: tang bx. Ann Oncol. 2022 Oct;33(10):1061-1070. doi: 10.1016/j.annonc.2022.07.002. Epub 2022 Jul 14. Ann Oncol. 2022. PMID: 35842199 Free article. Clinical Trial.
Erratum: MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways: Erratum.
Ma M, Dai J, Tang H, Xu T, Yu S, Si L, Cui C, Sheng X, Chi Z, Mao L, Wu X, Yang L, Yu H, Li S, Lian B, Tang B, Wang X, Yan X, Bai X, Zhou L, Kong Y, Guo J. Ma M, et al. Theranostics. 2022 Apr 26;12(7):3578-3579. doi: 10.7150/thno.72945. eCollection 2022. Theranostics. 2022. PMID: 35547776 Free PMC article.
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study.
Zhou L, Yang KW, Zhang S, Yan XQ, Li SM, Xu HY, Li J, Liu YQ, Tang BX, Chi ZH, Si L, Cui CL, Guo HQ, He ZS, Guo J, Sheng X. Zhou L, et al. Among authors: tang bx. Ann Oncol. 2024 Dec 9:S0923-7534(24)04977-9. doi: 10.1016/j.annonc.2024.12.002. Online ahead of print. Ann Oncol. 2024. PMID: 39662628
42 results